CLINICAL TRIALS PROFILE FOR ZARONTIN

All Clinical Trials for ZARONTIN

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00088452 ↗	Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	Phase 3	2004-07-01	The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00088452 ↗	Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study	Completed	Children's Hospital Medical Center, Cincinnati	Phase 3	2004-07-01	The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University Health Center	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 ↗	Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)	Terminated	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 2	2008-09-01	Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT01122381 ↗	Comparison of a Drug and Placebo in the Prevention of Migraine Headaches	Terminated	Thomas Jefferson University	Phase 1/Phase 2	2011-12-01	The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.

Clinical Trial Conditions for ZARONTIN

Condition Name

Condition Name for ZARONTIN
Intervention	Trials
Petit Mal Epilepsy	1
Seizures	1
Childhood Absence Epilepsy	1
Complex Regional Pain Syndromes	1

Condition MeSH

Condition MeSH for ZARONTIN
Intervention	Trials
Complex Regional Pain Syndromes	1
Neuralgia	1
Seizures	1
Migraine Disorders	1

Clinical Trial Locations for ZARONTIN

Trials by Country

Trials by Country for ZARONTIN
Location	Trials
United States	23
Canada	1
China	1
France	1

Trials by US State

Trials by US State for ZARONTIN
Location	Trials
Pennsylvania	2
Connecticut	1
Virginia	1
Washington	1
Wisconsin	1

Clinical Trial Progress for ZARONTIN

Clinical Trial Phase

Clinical Trial Phase for ZARONTIN
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	2
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for ZARONTIN
Clinical Trial Phase	Trials
Completed	2
Terminated	2
Unknown status	1

Clinical Trial Sponsors for ZARONTIN

Sponsor Name

Sponsor Name for ZARONTIN
Sponsor	Trials
Thomas Jefferson University	1
University of Pittsburgh	1
US Department of Veterans Affairs	1

Sponsor Type

Sponsor Type for ZARONTIN
Sponsor	Trials
Other	9
U.S. Fed	2
NIH	1